[
  {
    "ts": "2025-07-23T17:25:06+00:00",
    "headline": "Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend",
    "summary": "Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership changes. These developments coincided with the company's stock increasing 8% over the past month, aligning with the S&P 500's upward trend. The recent trial highlights BDX's focus on innovation in high-demand biologics, potentially enhancing market confidence. Similarly, the dividend declaration may...",
    "url": "https://finance.yahoo.com/news/becton-dickinson-bdx-unveils-wearable-172506648.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b0d1ea9b-36bb-30c1-9dd8-14c22a5d32c2",
      "content": {
        "id": "b0d1ea9b-36bb-30c1-9dd8-14c22a5d32c2",
        "contentType": "STORY",
        "title": "Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend",
        "description": "",
        "summary": "Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership changes. These developments coincided with the company's stock increasing 8% over the past month, aligning with the S&P 500's upward trend. The recent trial highlights BDX's focus on innovation in high-demand biologics, potentially enhancing market confidence. Similarly, the dividend declaration may...",
        "pubDate": "2025-07-23T17:25:06Z",
        "displayTime": "2025-07-23T17:25:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vLi2clQ39cq4H4GDgg1AAA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hLmZY7hCIZ66l74wpB8KIg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/becton-dickinson-bdx-unveils-wearable-172506648.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/becton-dickinson-bdx-unveils-wearable-172506648.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-23T13:20:39+00:00",
    "headline": "Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations",
    "summary": "Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index rose 10.94% in the second quarter of 2025, marking a rebound of the U.S. equities market. Aristotle Atlantic’s Core Equity strategy returned 14.43% gross of […]",
    "url": "https://finance.yahoo.com/news/becton-dickinson-company-bdx-fell-132039672.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "9e9057fb-79e5-3625-bc3c-73757930fb5f",
      "content": {
        "id": "9e9057fb-79e5-3625-bc3c-73757930fb5f",
        "contentType": "STORY",
        "title": "Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations",
        "description": "",
        "summary": "Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index rose 10.94% in the second quarter of 2025, marking a rebound of the U.S. equities market. Aristotle Atlantic’s Core Equity strategy returned 14.43% gross of […]",
        "pubDate": "2025-07-23T13:20:39Z",
        "displayTime": "2025-07-23T13:20:39Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/44a28f5e0176b2e6f788f1d7b92a3031",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Is Becton, Dickinson, and Company (BDX) the Best-Falling Stock to Buy According to Analysts?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SgLGKDaRUl0wX2jiLQUueg--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/44a28f5e0176b2e6f788f1d7b92a3031.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RbtQIq43pGSZoNEq7evsVQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/44a28f5e0176b2e6f788f1d7b92a3031.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/becton-dickinson-company-bdx-fell-132039672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/becton-dickinson-company-bdx-fell-132039672.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-23T10:50:00+00:00",
    "headline": "BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.",
    "url": "https://finance.yahoo.com/news/bd-announces-first-pharma-sponsored-105000478.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "870fc1cb-6d26-394c-8d86-f617c03fb2c5",
      "content": {
        "id": "870fc1cb-6d26-394c-8d86-f617c03fb2c5",
        "contentType": "STORY",
        "title": "BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs",
        "description": "",
        "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.",
        "pubDate": "2025-07-23T10:50:00Z",
        "displayTime": "2025-07-23T10:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/19384191331329ae7602176dc737e7d7",
          "originalWidth": 400,
          "originalHeight": 303,
          "caption": "BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WfLP2eQfBMNbFflMRfGNlg--~B/aD0zMDM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/19384191331329ae7602176dc737e7d7.cf.webp",
              "width": 400,
              "height": 303,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9WtdtNwQfuVK5g3UglMSZQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/19384191331329ae7602176dc737e7d7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-announces-first-pharma-sponsored-105000478.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-announces-first-pharma-sponsored-105000478.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]